Robot-assisted radical prostatectomy (RARP) is a rapidly evolving technique for the treatment of localized prostate cancer. In the United States, over 65% of radical prostatectomies are robot-assisted, although the acceptance of this technology in Europe and the rest of the world has been somewhat slower.
In this lecture, Prof. Artibani reviews his own experience as well as the current literature on RARP with regard to oncological, continence and potency outcomes. The preliminary data appear to show an advantage of RARP over open prostatectomy.